No image published for this recall

Acurate neo2 and acurate prime

Official notice

2 Dec 2024

CriticalHealth Canada

An official Health Canada notice concerns Acurate neo2 and acurate prime. Boston Scientific has become aware of new information related to valve underexpansion, that emerged from review of the 1-year clinical trial data from the ACURATE IDE. Detailed investigation of the 1-year data identified valve underexpansion as a potential leading contributing factor of the missed primary endpoint (ACURATE neo2 non- inferiority to the Control group for the composite of death, stroke and rehospitalisation). ACURATE neo2 valve underexpansion was associated with an increased rate of primary endpoint events compared to cases where the ACURATE neo2 valve was well expanded. However, valve underexpansion was not previously identified through clinical experiences with the ACURATE neo2 valve nor through ACURATE neo2 post market surveillance. The Instructions for Use (IFU) have been updated to include the risk of valve underexpansion and the practices that may reduce this risk. Recall start date: November 7, 2024 Published 2024-12-02.

What to do now

Contact the manufacturer if you require additional information.

Recall number

76521

Official notice

2024-12-02

The hazard

Boston Scientific has become aware of new information related to valve underexpansion, that emerged from review of the 1-year clinical trial data from the ACURATE IDE. Detailed investigation of the 1-year data identified valve underexpansion as a potential leading contributing factor of the missed primary endpoint (ACURATE neo2 non- inferiority to the Control group for the composite of death, stroke and rehospitalisation). ACURATE neo2 valve underexpansion was associated with an increased rate of primary endpoint events compared to cases where the ACURATE neo2 valve was well expanded. However, valve underexpansion was not previously identified through clinical experiences with the ACURATE neo2 valve nor through ACURATE neo2 post market surveillance. The Instructions for Use (IFU) have been updated to include the risk of valve underexpansion and the practices that may reduce this risk. Recall start date: November 7, 2024

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Recall Numbers

76521

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Affected products

Product 1

Affected products - ACURATE Prime Aortic Valve, Lot or serial number - All lots., Model or catalogue number - H74939690250 H74939690270 H74939690230 H74939690290

Product 2

Affected products - ACURATE Neo2 Loading Kit, Lot or serial number - All lots., Model or catalogue number - SYM-AC-010

Product 3

Affected products - ACURATE Prime Delivery System, Lot or serial number - All lots., Model or catalogue number - H749396822729 H749396822325

Product 4

Affected products - ACURATE Neo2 Transfemoral Delivery System, Lot or serial number - All lots., Model or catalogue number - SYM-DS-005 SYM-DS-010

Product 5

Affected products - ACURATE Prime Loading Kit, Lot or serial number - All lots., Model or catalogue number - H749396942729 H749396942325

Product 6

Affected products - ACURATE Neo2 Valve, Lot or serial number - All lots., Model or catalogue number - SYM-SV27-004 SYM-SV23-004 SYM-SV25-004

Product 7

Affected products - ACURATE Prime XL Delivery System, Lot or serial number - All lots., Model or catalogue number - SYM-DS-009-C

Product 8

Affected products - ACURATE Prime XL Loading Kit, Lot or serial number - All lots., Model or catalogue number - SYM-AC-009-C

Product 9

Affected products - ACURATE Prime XL Aortic Valve, Lot or serial number - All lots., Model or catalogue number - SYM-SV29-009-C

Risk / hazard

Boston Scientific has become aware of new information related to valve underexpansion, that emerged from review of the 1-year clinical trial data from the ACURATE IDE. Detailed investigation of the 1-year data identified valve underexpansion as a potential leading contributing factor of the missed primary endpoint (ACURATE neo2 non- inferiority to the Control group for the composite of death, stroke and rehospitalisation). ACURATE neo2 valve underexpansion was associated with an increased rate of primary endpoint events compared to cases where the ACURATE neo2 valve was well expanded. However, valve underexpansion was not previously identified through clinical experiences with the ACURATE neo2 valve nor through ACURATE neo2 post market surveillance. The Instructions for Use (IFU) have been updated to include the risk of valve underexpansion and the practices that may reduce this risk. Recall start date: November 7, 2024

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

CA · Canada

Affected area 1

CA · Canada

Company & contacts

Manufacturer

Not provided

Phone

Not provided

Brand: Boston Scientific, Acurate Neo2 And Acurate Prime.

Source & status

Source

Health Canada

Tier

official

Category

HEALTH

Classification

Type I

App estimate

critical

Recall details

Recall number

76521

Classification

Type I

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Related recalls

HEALTH
Medium

Faradrive™ steerable sheath

Health Canada19 Jun 2026

Brand match

Medium risk

Markets

CA
HEALTH
Medium

Icefx™ cryoablation console

Health Canada11 Sept 2025

Brand match

Medium risk

Markets

CA
HEALTH
High

Accolade™ and visionist™ crt-p pacemakers

Health Canada22 Aug 2025

Brand match

High risk

Markets

CA
HEALTH
Medium

Encore™ 26 inflation device, encore™ 26 advantage kits, nephromax™ kits and uromax ultra™ kits

Health Canada14 Aug 2025

Brand match

Medium risk

Markets

CA
HEALTH
High

Watchman™ access systems

Health Canada30 Jul 2025

Brand match

High risk

Markets

CA
HEALTH
Critical

Reliance defibrillation leads

Health Canada29 Jul 2025

Brand match

Critical risk

Markets

CA
HEALTH
High

Carotid wallstent™ monorail

Health Canada11 Jul 2025

Brand match

High risk

Markets

CA
HEALTH
Medium

Avvigo™+ multi-modality guidance system

Health Canada18 Dec 2024

Brand match

Medium risk

Markets

CA
HEALTH
High

Polarx fit short and long tip cryoablation balloon catheter

Health Canada15 Oct 2024

Brand match

High risk

Markets

CA
HEALTH
High

Accolade™ mri pacemaker

Health Canada24 Sept 2024

Brand match

High risk

Markets

CA
HEALTH
Medium

Expo angiographic catheters

Health Canada3 Apr 2024

Brand match

Medium risk

Markets

CA
HEALTH
Medium

Isleeve™ expandable introducer set

Health Canada29 Feb 2024

Brand match

Medium risk

Markets

CA

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 2 Dec 2024. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.